The Patent Finder

Karuna Therapeutics, Inc.

Also on record
Records under this name other than the patents Karuna Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Back to Karuna Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
16/950,203Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
Abandoned
Abandoned May 14, 2024
AbandonedAbandoned May 14, 2024
17/167,714Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
Abandoned
Abandoned Dec 3, 2022
AbandonedAbandoned Dec 3, 2022
17/310,735Compounds and Methods of Deuterated Xanomeline for Treating Neurological Disorders
Abandoned
Abandoned Dec 10, 2024
AbandonedAbandoned Dec 10, 2024
17/663,760Methods for Treating Central Nervous System Disorders with Muscarinic Receptor Activation and Antipsychotics
Abandoned
Abandoned Jan 17, 2024
AbandonedAbandoned Jan 17, 2024
18/454,177Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/853,947Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/138,334Substituted Tetrahydropyrrolo-Pyridinone Compounds and Their Use in Treating Medical Conditions
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/138,349Substituted Tetrahydropyrrolo-Pyridinone Compounds and Their Use in Treating Medical Conditions
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/138,393Substituted Dihydropyrrolo[3,4-d]pyrimidine Compounds and Their Use in Treating Medical Conditions
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/138,408Substituted Dihydropyrrolo[3,4-d]pyrimidine Compounds and Their Use in Treating Medical Conditions
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 12 records shown.
Pro members see all 12.
Pro members: see all 12 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited